Recent reports suggest that ADAMTS2 is overexpressed by gastric cancer cells, COL14A1 is downregulated in breast cancer cells, and ADAMTS15 functions as a tumor suppressor role in prostate cancer (Jiang et al. 2019; Binder et al. 2020; Malvia et al. 2023). This evidence concerns the gene ADAMTS2 and prostate cancer.